aica ribonucleotide and Glioblastoma

aica ribonucleotide has been researched along with Glioblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cloughesy, TF; Czernin, J; Dang, J; Guo, D; Hildebrandt, IJ; Mazzotta, MM; Mischel, PS; Phelps, M; Prins, RM; Radu, CG; Shyy, JY; Soto, H; Watson, AD	1

Other Studies

1 other study(ies) available for aica ribonucleotide and Glioblastoma

Article	Year
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proceedings of the National Academy of Sciences of the United States of America, 2009, Aug-04, Volume: 106, Issue:31 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Glioblastoma; Humans; Lipogenesis; Mice; Protein Kinases; PTEN Phosphohydrolase; Ribonucleotides; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2009

Article

Year

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.

Proceedings of the National Academy of Sciences of the United States of America, 2009, Aug-04, Volume: 106, Issue:31

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Glioblastoma; Humans; Lipogenesis; Mice; Protein Kinases; PTEN Phosphohydrolase; Ribonucleotides; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2009